- Home
- MASS vs ARMP Comparison
MASS vs ARMP Comparison
Compare MASS & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MASS
- ARMP
- Stock Information
- Founded
- MASS 2012
- ARMP N/A
- Country
- MASS United States
- ARMP United States
- Employees
- MASS N/A
- ARMP N/A
- Industry
- MASS Medical/Dental Instruments
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MASS Health Care
- ARMP Health Care
- Exchange
- MASS Nasdaq
- ARMP Nasdaq
- Market Cap
- MASS 79.7M
- ARMP 80.0M
- IPO Year
- MASS 2020
- ARMP N/A
- Fundamental
- Price
- MASS $2.88
- ARMP $2.25
- Analyst Decision
- MASS Buy
- ARMP Strong Buy
- Analyst Count
- MASS 3
- ARMP 1
- Target Price
- MASS $5.33
- ARMP $7.00
- AVG Volume (30 Days)
- MASS 1.2M
- ARMP 13.8K
- Earning Date
- MASS 03-04-2025
- ARMP 11-13-2024
- Dividend Yield
- MASS N/A
- ARMP N/A
- EPS Growth
- MASS N/A
- ARMP N/A
- EPS
- MASS N/A
- ARMP N/A
- Revenue
- MASS $55,162,000.00
- ARMP $5,467,000.00
- Revenue This Year
- MASS $15.31
- ARMP $23.87
- Revenue Next Year
- MASS $16.10
- ARMP N/A
- P/E Ratio
- MASS N/A
- ARMP N/A
- Revenue Growth
- MASS 16.08
- ARMP 34.92
- 52 Week Low
- MASS $1.81
- ARMP $1.80
- 52 Week High
- MASS $8.50
- ARMP $4.48
- Technical
- Relative Strength Index (RSI)
- MASS 60.16
- ARMP 60.64
- Support Level
- MASS $1.97
- ARMP $1.97
- Resistance Level
- MASS $3.29
- ARMP $2.28
- Average True Range (ATR)
- MASS 0.29
- ARMP 0.14
- MACD
- MASS 0.12
- ARMP 0.03
- Stochastic Oscillator
- MASS 66.79
- ARMP 91.67
About MASS 908 Devices Inc.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.